An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.


Updates from The Motley Fool

Latest updates on EXACT Sciences from Fool.com.


Stock Performance

EXAS vs. S&P 500 | 2 Year Performance
View Interactive EXAS Charts
Sponsored by

Key Data Points

Primary metrics and data points about EXACT Sciences.
Current Price: $18.57
Prev Close: $17.68
Open: $17.79
Bid: $18.00
Ask: $18.50
Day's Range: $17.69 - $18.70
52wk Range: $4.67 - $22.80
Volume: 2,806,957
Avg Vol 2,476,723
Market Cap: $2B
P/E (ttm): -9.71
EPS (ttm): ($1.82)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about EXACT Sciences.
CAPS Rating 2 out of 5
 
223 Outperform
38 Underperform
CAPS All Stars
 
39 Outperform
14 Underperform

How do you think EXACT Sciences will perform against the market?



You pick for EXACT Sciences is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kevin T. Conroy, CEO

78% Approve

Based on 18 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for EXACT Sciences.

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers